360° Coverage : Paid COPD Clinical Trial Now Enrolling at Avail Clinical...

1 Updates

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us...

Filed under: news

YouTube Videos

 
 
 

1 year ago

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may receive compensation for time and travel.

Study Design
This study is designed to evaluate the effect of an experimental inhalation therapy administered once daily via a Novel Dry Powder Inhaler on arterial stiffness compared with placebo and vilanterol over a 24 - week treatment period in subjects with COPD. Vilanterol is included to help explain relative treatment effect of this experimental inhalation therapy in the new combination, however the comparison is not powered. Arterial stiffness will be measured as aPWV. This is a randomised, placebo-controlled, multicenter study. Subjects who meet the eligibility criteria at Screening and meeting the randomisation criteria at the end of a 2-week Run-In period will enter a 24-week treatment period. There will be an approximately 7-day Follow-Up period after the treatment period.

Background & Rationale
Arterial stiffness is increasingly recognized as a surrogate marker for cardiovascular disease (CVD). In particular, arterial stiffness has been shown to be an independent predictor of future fatal and non-fatal CV events and all-cause mortality in hypertensive patients, apparently healthy elderly subjects and a general population. Arterial stiffness can be measured with non-invasive, reproducible and inexpensive techniques, which make it feasible to implement into clinical practice and large-scale clinical studies.

Primary Objectives
The primary objective of the study is to evaluate the effect of an experimental inhalation therapy administered once daily (QD) compared with placebo on aPWV in subjects with COPD and aPWV ≥ 11.0 m/s at baseline.

Inclusion Criteria
1. Type of subject: outpatient
2. Informed consent: Subjects must give their signed and dated written informed consent to participate.
3. Gender: Male or female subjects

A female is eligible to enter and participate in the study if she is of:
-Non-child bearing potential (i.e., physiologically incapable of becoming pregnant, including any female who is post-menopausal or surgically sterile).
-Child bearing potential, has a negative pregnancy test at screening, and agrees to one of the following acceptable contraceptive methods used consistently and correctly:
-- Complete abstinence from intercourse from screening until the Follow-Up Phone Contact; or
-- Male partner is sterile (vasectomy with documentation of azoospermia) prior to female subject entry into the study, and this male partner is the sole partner for that subject; or
-- Implants of levonorgestrel inserted for at least 1 month prior to the study medication administration but not beyond the third successive year following insertion; or
-- Injectable progestogen administered for at least 1 month prior to study medication administration and administered until the Follow-Up Phone Contact; or
-- Oral contraceptive (combined or progestogen only) administered for at least one monthly cycle prior to study medication administration; or
-- Double barrier method: condom and occlusive cap (diaphragm or cervical/vault caps) with spermicidal agent (foam/gel/film/cream/suppository); or
-- An intrauterine device (IUD), inserted by a qualified physician, with published data showing that the highest expected failure rate is less than 1 per year; or
-- Estrogenic vaginal ring; or
-- Percutaneous contraceptive patches

4. Age: ≥40 years of age at Screening (Visit 1)
5. COPD diagnosis: Subjects with a clinical history of COPD
6. Tobacco use: Subjects with a current or prior history of ≥10 pack-years of cigarette smoking at Screening
7. Severity of Disease:

Subjects with a measured post-albuterol/salbutamol FEV1 ≤70% of predicted normal values calculated using NHANES III reference equations at Screening (Visit 1)
Subject with a measured post-albuterol/salbutamol FEV1/FVC ratio of ≤0.70 at Screening (Visit 1)
Post-bronchodilator spirometry will be performed approximately 10-15 minutes after
the subject has self-administered 4 inhalations (i.e., total 400mcg) of albuterol/salbutamol via an MDI with a valved-holding chamber.
8. Baseline aPWV: subjects with a measured aPWV≥11.0 m/s at Screening (Visit 1)

Contact Information:
Avail Clinical Research
Jennifer Economou
(386) 785-2400 336
Contact via Email
www.availclinical.com

Read the full story here: http://www.pr.com/press-release/518663

Press Release Distributed by PR.com

Source: PR.com

 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

Thai scientists discover antibody to cure Ebola
Bangkok, Oct 2 (IANS/EFE) Thai scientists Thursday announced the discovery of a new antibody against the Ebola virus and claimed that it is "more effective" than those that now exist.
 
 
Newly discovered deviant ant species!
Washington, Oct 2 (IANS) People often say that what you are looking for is usually right in front of your face. Researchers from the George Washington University in the US faced the same predicament when they discovered an ant species, Cephalotes specularis, hiding in plain sight.
 
 
Specific network exists in brain for using tools
London, Oct 2 (IANS) Scientists in Munich, while examining the parts of the brain that are responsible for planning and executing complex actions, have discovered that there is a specific network for using tools and utensils.
 
 
Short, intense workouts boost memory
Washington, Oct 2 (IANS) An intense workout for as little as 20 minutes can enhance episodic or long term memory about previous events by about 10 percent in healthy young adults, say researchers.
 
 
 

Latest from the Network

George Clooney praises his wedding singer
George Clooney asked an unknown singer to perform at his wedding. The 'Monuments Men' actor and his new wife, human rights barrister, Amal Alamuddin, decided against asking a well known pop star to sing at their...
Read more on Celebrity Balla
 
Jennifer Love Hewitt's daughter does Zumba
Jennifer Love Hewitt's 10-month-old daughter goes to Zumba classes. The 35-year-old actress takes her baby girl Autumn most places with her and the tot joins in when she participates in the dance-based exercise. Autumn...
Read more on Celebrity Balla
 
Iran suspends sentences for participants in 'Happy' video
Tehran, Oct 2 (IANS/EFE) Iranian authorities have suspended for three years the tough sentences handed to seven Iranian youths who filmed a video dancing to Pharrell Williams' "Happy". The sentence, which included...
Read more on Politics Balla
 
Inderjeet wins men's shot put bronze at Asiad
Incheon, Oct 2 (IANS) India's Inderjeet Singh took home the bronze medal from the men's shot put final at the Asian Games here Thursday. The Indian's best throw of 19.63 metres came on his fifth attempt, out of six,...
Read more on Sport Balla
 
Stefan Lofven voted new Swedish prime minister
Stockholm, Oct 2 (IANS) Stefan Lofven, head of the Social Democratic Party, was Thursday voted by parliament to be the new Swedish prime minister. Lofven got 132 "yes" votes in the 349-seat Parliament, with 49 "no"...
Read more on Politics Balla
 
Indians finish 4th, 5th in men's 10 km final
Incheon, Oct 2 (IANS) Indian runners Rahul Kumar Pal and Suresh Kumar set their personal best times to finish a creditable fourth and fifth in the men's 10,000 metres final at the Asian Games here Thursday. Bahrain's...
Read more on Sport Balla
 
Surfer loses arm, other hand in shark attack
Sydney Oct 2 (IANS/EFE) A 23-year-old surfer lost one of his arms and his other hand in a shark attack Thursday at a beach near Esperance in Western Australia, official sources reported. The youth was attacked in the...
Read more on Politics Balla
 
Indian boxers Vikas, Satish settle for bronze medals (Third Lead)
Incheon, Oct 2 (IANS) India's campaign in Asian Games boxing ended Thursday with Vikas Krishan and Satish Kumar settling for the bronze medals after losing their respective semi-final bouts to Kazakhstan pugilists at...
Read more on Sport Balla
 
Arpinder, Renjith finish 5th, 9th in triple jump
Incheon, Oct 2 (IANS) Indian athletes Arpinder Singh and Renjith Maheshwary failed to secure any medal from the men's triple jump final, finishing fifth and ninth respectively, at the 17th Asian Games here Thursday....
Read more on Sport Balla
 
India's Inderjeet wins men's shot put bronze
Incheon, Oct 2 (IANS) India's Inderjeet Singh clinched the bronze in the men's shot put final at the Asian Games here Thursday. Saudi Arabia's Sultan Abdulmajeed Alhebshi won the gold with a best throw of 19.99 metres...
Read more on Sport Balla